The Regulation of Differentiation in Mesenchymal Stem Cells

Mesenchymal stromal/stem cells (MSCs) are a population of stromal cells present in the bone marrow and most connective tissues, capable of differentiation into mesenchymal tissues such as bone and cartilage. MSCs are attractive candidates for biological cell-based tissue repair approaches because of their extensive proliferative ability in culture while retaining their mesenchymal multilineage differentiation potential. In addition to its undoubted scientific interest, the prospect of monitoring and controlling MSC differentiation is a crucial regulatory and clinical requirement. Hence, the molecular regulation of MSC differentiation has been extensively studied. Most of the studies are in vitro, because the identity of MSCs in their tissues of origin in vivo remains undefined. This review addresses the current knowledge of the molecular basis of differentiation of cultured MSCs, with a particular focus on chondrogenesis and osteogenesis. Building on the information coming from developmental biology studies of embryonic skeletogenesis, several signaling pathways and transcription factors have been investigated and shown to play critical roles in MSC differentiation. In particular, the Wnt and transforming growth factor-β/bone morphogenetic protein signaling pathways are well known to modulate in MSCs the molecular differentiation into cartilage and bone. Relevant to the emerging concept of stem cell niches is the demonstration that physical factors can also participate in the regulation of MSC differentiation. Knowledge of the regulation of MSC differentiation will be critical in the design of three-dimensional culture systems and bioreactors for automated bioprocessing through mathematical models applied to systems biology and network science.

[1]  J. Fisher,et al.  Human mesenchymal stem cell position within scaffolds influences cell fate during dynamic culture , 2012, Biotechnology and bioengineering.

[2]  Claire Yu,et al.  Co-delivery of adipose-derived stem cells and growth factor-loaded microspheres in RGD-grafted N-methacrylate glycol chitosan gels for focal chondral repair. , 2012, Biomacromolecules.

[3]  S. Bauer,et al.  Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells. , 2012, Tissue engineering. Part C, Methods.

[4]  V. Faça Human mesenchymal stromal cell proteomics: contribution for identification of new markers and targets for medicine intervention , 2012, Expert review of proteomics.

[5]  R. Gambari,et al.  Role of Slug transcription factor in human mesenchymal stem cells , 2012, Journal of cellular and molecular medicine.

[6]  Muhammad Khan,et al.  Increased differentiation capacity of bone marrow-derived mesenchymal stem cells in aquaporin-5 deficiency. , 2012, Stem cells and development.

[7]  S. Saraswati,et al.  Pyrvinium, a potent small molecule Wnt inhibitor, increases engraftment and inhibits lineage commitment of mesenchymal stem cells (MSCs) , 2012, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[8]  R. Müller,et al.  Lentiviral-mediated integrin α5 expression in human adult mesenchymal stromal cells promotes bone repair in mouse cranial and long-bone defects. , 2012, Human gene therapy.

[9]  S. Kang,et al.  SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC , 2011, Cell Death and Differentiation.

[10]  Qing Yang,et al.  Intracoronary transplantation of genetically modified mesenchymal stem cells, a novel method to close muscular ventricular septal defects. , 2011, Medical hypotheses.

[11]  J. Hunt,et al.  The use of dynamic surface chemistries to control msc isolation and function. , 2011, Biomaterials.

[12]  Jin Wook Hwang,et al.  Enhanced chondrogenic marker expression of human mesenchymal stem cells by interaction with both TGF‐β3 and hyaluronic acid , 2011, Biotechnology and applied biochemistry.

[13]  D. Coutu,et al.  Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. , 2011, Blood.

[14]  H. Cheung,et al.  Activation of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) is needed for the TGFβ-induced chondrogenic and osteogenic differentiation of mesenchymal stem cells. , 2011, Biochemical and biophysical research communications.

[15]  A. Cheng,et al.  SOX9 determines RUNX2 transactivity by directing intracellular degradation , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  A. Augello,et al.  Mesenchymal stem cells from development to postnatal joint homeostasis, aging, and disease. , 2010, Birth defects research. Part C, Embryo today : reviews.

[17]  Tao Wang,et al.  miR-27 promotes osteoblast differentiation by modulating Wnt signaling. , 2010, Biochemical and biophysical research communications.

[18]  K. Sakamoto,et al.  Osteogenic differentiation of mouse mesenchymal progenitor cell, Kusa-A1 is promoted by mammalian transcriptional repressor Rbpj. , 2010, Biochemical and biophysical research communications.

[19]  G. Im,et al.  The effects of Wnt inhibitors on the chondrogenesis of human mesenchymal stem cells. , 2010, Tissue engineering. Part A.

[20]  M. Longaker,et al.  Opposite spectrum of activity of canonical Wnt signaling in the osteogenic context of undifferentiated and differentiated mesenchymal cells: implications for tissue engineering. , 2010, Tissue engineering. Part A.

[21]  G. Gronowicz,et al.  miR-29 Modulates Wnt Signaling in Human Osteoblasts through a Positive Feedback Loop* , 2010, The Journal of Biological Chemistry.

[22]  C. Deng,et al.  The Balance of WNT and FGF Signaling Influences Mesenchymal Stem Cell Fate During Skeletal Development , 2010, Science Signaling.

[23]  Ivan Martin,et al.  Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering , 2010, Proceedings of the National Academy of Sciences.

[24]  F. Dell’Accio,et al.  Distinct mesenchymal progenitor cell subsets in the adult human synovium. , 2009, Rheumatology.

[25]  M. Selig,et al.  Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes1 , 2009, The Journal of Immunology.

[26]  Ichiro Takada,et al.  Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis , 2009, Nature Reviews Rheumatology.

[27]  Tomislav Smoljanovic,et al.  Bone morphogenetic protein. , 2009, Journal of neurosurgery. Spine.

[28]  G. Camussi,et al.  Isolation and characterization of resident mesenchymal stem cells in human glomeruli. , 2009, Stem cells and development.

[29]  David L. Kaplan,et al.  Role of Membrane Potential in the Regulation of Cell Proliferation and Differentiation , 2009, Stem Cell Reviews and Reports.

[30]  J. Schrooten,et al.  A clinically relevant model of osteoinduction: a process requiring calcium phosphate and BMP/Wnt signalling , 2009, Journal of cellular and molecular medicine.

[31]  D. Lauffenburger,et al.  Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi‐potent marrow stromal cells , 2009, Journal of cellular physiology.

[32]  D. E. Discher,et al.  Matrix elasticity directs stem cell lineage — Soluble factors that limit osteogenesis , 2009 .

[33]  A. Iwama,et al.  MicroRNA‐27 enhances differentiation of myeloblasts into granulocytes by post‐transcriptionally downregulating Runx1 , 2009, British journal of haematology.

[34]  S. Aaronson,et al.  Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells , 2009, The Journal of cell biology.

[35]  Luke H. Hoeppner,et al.  Wnt signaling as a therapeutic target for bone diseases , 2009, Expert opinion on therapeutic targets.

[36]  L. Matukumalli,et al.  MicroRNA transcriptome profiles during swine skeletal muscle development , 2009, BMC Genomics.

[37]  N. Z. Zur Nieden,et al.  Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering. , 2008, Tissue engineering. Part B, Reviews.

[38]  J. John Mann,et al.  Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum , 2008, Cell.

[39]  David L. Kaplan,et al.  Membrane Potential Controls Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells , 2008, PloS one.

[40]  J. Joh,et al.  Isolation and characterization of mouse mesenchymal stem cells. , 2008, Transplantation proceedings.

[41]  G. Karsenty Transcriptional control of skeletogenesis. , 2008, Annual review of genomics and human genetics.

[42]  Y. Ishii,et al.  PDGF Receptor β Is a Potent Regulator of Mesenchymal Stromal Cell Function , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  H. Luder,et al.  Stem cells for tooth engineering. , 2008, European cells & materials.

[44]  C. Choong,et al.  PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. , 2008, Blood.

[45]  S. Goldenberg,et al.  Dissimilar Differentiation of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, and Adipose Tissue , 2008, Experimental biology and medicine.

[46]  A. Uitterlinden,et al.  Wnt signaling acts and is regulated in a human osteoblast differentiation dependent manner , 2008, Journal of cellular biochemistry.

[47]  Luke H. Hoeppner,et al.  Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1 (Lef1) and negatively regulates osteoblast maturation. , 2008, Matrix biology : journal of the International Society for Matrix Biology.

[48]  F. Dell’Accio,et al.  Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. , 2008, Arthritis and rheumatism.

[49]  Y. Okazaki,et al.  miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. , 2008, Biochemical and biophysical research communications.

[50]  Bernhard Schmierer,et al.  TGFβ–SMAD signal transduction: molecular specificity and functional flexibility , 2007, Nature Reviews Molecular Cell Biology.

[51]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[52]  R. Tuan,et al.  Comparison of Proliferative and Multilineage Differentiation Potential of Human Mesenchymal Stem Cells Derived from Umbilical Cord and Bone Marrow , 2007, Stem cells.

[53]  P. Tiberghien,et al.  Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule , 2007, Cell and Tissue Research.

[54]  Thomas Aigner,et al.  Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. , 2006, Arthritis and rheumatism.

[55]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[56]  R. Nusse,et al.  Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors* , 2006, Journal of Biological Chemistry.

[57]  R. Tuan,et al.  Identification and Functional Analysis of Candidate Genes Regulating Mesenchymal Stem Cell Self‐Renewal and Multipotency , 2006, Stem cells.

[58]  E. Schwarz,et al.  Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor , 2006, Journal of cellular physiology.

[59]  Lindolfo da Silva Meirelles,et al.  Mesenchymal stem cells reside in virtually all post-natal organs and tissues , 2006, Journal of Cell Science.

[60]  Gil Navon,et al.  Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. , 2006, The Journal of clinical investigation.

[61]  G. Stein,et al.  Lymphocyte enhancer‐binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts , 2006, Journal of cellular biochemistry.

[62]  Francesco Dell'Accio,et al.  Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. , 2006, Arthritis and rheumatism.

[63]  Vivian H. Fan,et al.  Epidermal Growth Factor as a Candidate for Ex Vivo Expansion of Bone Marrow–Derived Mesenchymal Stem Cells , 2006, Stem cells.

[64]  J. H. Kim,et al.  Endogenous Wnt signaling promotes proliferation and suppresses osteogenic differentiation in human adipose derived stromal cells. , 2006, Tissue engineering.

[65]  J. Westendorf,et al.  Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. , 2005, Birth defects research. Part C, Embryo today : reviews.

[66]  A. Scarpa,et al.  HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. , 2005, Blood.

[67]  Blagoy Blagoev,et al.  Mechanism of Divergent Growth Factor Effects in Mesenchymal Stem Cell Differentiation , 2005, Science.

[68]  Xizhi Guo,et al.  Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. , 2005, Developmental cell.

[69]  R. Tuan,et al.  N‐cadherin mediated distribution of β‐catenin alters MAP kinase and BMP‐2 signaling on chondrogenesis‐related gene expression , 2005, Journal of cellular biochemistry.

[70]  Walter Birchmeier,et al.  Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. , 2005, Developmental cell.

[71]  I. Sekiya,et al.  Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma , 2005, Cell and Tissue Research.

[72]  G. Boland,et al.  Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells , 2004, Journal of cellular biochemistry.

[73]  Karl Kingsley,et al.  Laminin-5 induces osteogenic gene expression in human mesenchymal stem cells through an ERK-dependent pathway. , 2004, Molecular biology of the cell.

[74]  M. Bouxsein,et al.  Decreased BMD and Limb Deformities in Mice Carrying Mutations in Both Lrp5 and Lrp6 , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[75]  Di Chen,et al.  Bone Morphogenetic Proteins , 2004, Growth factors.

[76]  J. Westendorf,et al.  Wnt signaling in osteoblasts and bone diseases. , 2004, Gene.

[77]  D. Heath,et al.  Expression Profiling and Functional Analysis of Wnt Signaling Mechanisms in Mesenchymal Stem Cells , 2004, Stem cells.

[78]  P. McCrea,et al.  Interactions between Sox9 and β-catenin control chondrocyte differentiation , 2004 .

[79]  N. Jørgensen,et al.  Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts , 2004, Steroids.

[80]  B. Larson,et al.  Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. , 2004, Blood.

[81]  Antal Rot,et al.  Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions , 2004, Platelets.

[82]  T. Einhorn,et al.  BMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesis , 2003, Journal of cellular biochemistry.

[83]  W. Revell,et al.  Observations of subchondral plate advancement during osteochondral repair: a histomorphometric and mechanical study in the rabbit femoral condyle. , 2003, Osteoarthritis and cartilage.

[84]  W. Hozack,et al.  Transforming Growth Factor-β-mediated Chondrogenesis of Human Mesenchymal Progenitor Cells Involves N-cadherin and Mitogen-activated Protein Kinase and Wnt Signaling Cross-talk* , 2003, Journal of Biological Chemistry.

[85]  E. Wagner,et al.  Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart , 2003, Development.

[86]  Jennifer J Westendorf,et al.  Lymphoid Enhancer Factor-1 and β-Catenin Inhibit Runx2-dependent Transcriptional Activation of the Osteocalcin Promoter* , 2003, The Journal of Biological Chemistry.

[87]  R. Tuan Cellular Signaling in Developmental Chondrogenesis: N-Cadherin, Wnts, and BMP-2 , 2003, The Journal of bone and joint surgery. American volume.

[88]  J. Vermeesch,et al.  Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane , 2003, The Journal of cell biology.

[89]  Paul Emery,et al.  Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. , 2002, Arthritis and rheumatism.

[90]  P. Knaus,et al.  Integration of the TGF-β pathway into the cellular signalling network , 2002 .

[91]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[92]  L. Hofbauer,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[93]  R. Tuan,et al.  Multilineage mesenchymal differentiation potential of human trabecular bone‐derived cells , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[94]  S. Harris,et al.  Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation , 2002, The Journal of cell biology.

[95]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[96]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[97]  Darwin J. Prockop,et al.  In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[98]  A. Manira,et al.  Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[99]  Manas Kumar Majumdar,et al.  BMP‐2 and BMP‐9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL‐1 , 2001, Journal of cellular physiology.

[100]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[101]  F. Barry,et al.  Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. , 2001, Experimental cell research.

[102]  F. Luyten,et al.  Multipotent mesenchymal stem cells from adult human synovial membrane. , 2001, Arthritis and rheumatism.

[103]  F. Luyten,et al.  Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. , 2001, Arthritis and rheumatism.

[104]  I. Sekiya,et al.  BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. , 2001, Biochemical and biophysical research communications.

[105]  S. Bruder,et al.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. , 2001, Trends in molecular medicine.

[106]  I. Black,et al.  Adult rat and human bone marrow stromal stem cells differentiate into neurons. , 2001, Blood cells, molecules & diseases.

[107]  R Cancedda,et al.  Repair of large bone defects with the use of autologous bone marrow stromal cells. , 2001, The New England journal of medicine.

[108]  R Cancedda,et al.  Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. , 2000, Journal of cell science.

[109]  A Boyde,et al.  Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. , 2000, Journal of biomedical materials research.

[110]  C. Heldin,et al.  Specificity, diversity, and regulation in TGF‐β superfamily signaling , 1999 .

[111]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[112]  D. Rowe,et al.  Receptor tyrosine kinase expression in human bone marrow stromal cells , 1998, Journal of cellular physiology.

[113]  J. Compston,et al.  Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. , 1998, Bone.

[114]  R Cancedda,et al.  A nude mouse model for human bone formation in unloaded conditions. , 1998, Bone.

[115]  A I Caplan,et al.  In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. , 1998, Experimental cell research.

[116]  F. Lecanda,et al.  Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein‐2 , 1997, Journal of cellular biochemistry.

[117]  A I Caplan,et al.  Stimulatory Effects of Basic Fibroblast Growth Factor and Bone Morphogenetic Protein‐2 on Osteogenic Differentiation of Rat Bone Marrow‐Derived Mesenchymal Stem Cells , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[118]  I. Martin,et al.  Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. , 1997, Endocrinology.

[119]  D. Prockop Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[120]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[121]  B. Hogan,et al.  Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.

[122]  A. Caplan,et al.  Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidine , 1995, Muscle & nerve.

[123]  S. Bruder,et al.  In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. , 1991, Experimental cell research.

[124]  C. R. Howlett,et al.  Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. , 1980, Clinical orthopaedics and related research.

[125]  H. Broxmeyer,et al.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. , 1980, Blood.

[126]  N. Kulagina,et al.  Fibroblast precursors in normal and irradiated mouse hematopoietic organs. , 1976, Experimental hematology.

[127]  A. Friedenstein,et al.  THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.

[128]  Christopher J Murphy,et al.  Modulation of osteogenic differentiation in hMSCs cells by submicron topographically-patterned ridges and grooves. , 2012, Biomaterials.

[129]  S. Kullman,et al.  TCDD disrupts hypural skeletogenesis during medaka embryonic development. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[130]  Lai Xiao-yu Changes of telomerase activity during differentiation of human mesenchymal stem cells into adipocytes , 2011 .

[131]  Kohei Miyazono,et al.  Bone morphogenetic protein receptors and signal transduction. , 2010, Journal of biochemistry.

[132]  Toshihisa Komori,et al.  Regulation of bone development and extracellular matrix protein genes by RUNX2 , 2009, Cell and Tissue Research.

[133]  H. Koo,et al.  Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. , 2009, Cellular immunology.

[134]  F. Luyten,et al.  A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. , 2008, Arthritis and rheumatism.

[135]  F. Dell’Accio,et al.  Cell therapy: a challenge in modern medicine. , 2008, Bio-medical materials and engineering.

[136]  K. Miyazono,et al.  5 The Bone Morphogenetic Proteins , 2008 .

[137]  R. Derynck,et al.  2 TGF-β and the TGF-β Family , 2008 .

[138]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[139]  Francesco Dell'Accio,et al.  Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. , 2004, Arthritis and rheumatism.

[140]  G. Boland,et al.  Wnt signaling during BMP‐2 stimulation of mesenchymal chondrogenesis , 2002, Journal of cellular biochemistry.

[141]  Mark L. Johnson,et al.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.

[142]  F. Luyten,et al.  Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. , 2001, Arthritis and rheumatism.

[143]  R. Tuan,et al.  Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: II. Stimulation by bone morphogenetic protein-2 requires modulation of N-cadherin expression and function. , 1999, Differentiation; research in biological diversity.

[144]  R. Tuan,et al.  Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. , 1999, Differentiation; research in biological diversity.

[145]  A M Mackay,et al.  Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. , 1998, Tissue engineering.

[146]  B. Shenker,et al.  Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. , 1994, Developmental biology.

[147]  E. Wang,et al.  Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. , 1993, Growth factors.

[148]  A. Caplan,et al.  Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. , 1992, Bone.

[149]  H. Ohgushi,et al.  Osteogenic capacity of rat and human marrow cells in porous ceramics. Experiments in athymic (nude) mice. , 1990, Acta orthopaedica Scandinavica.

[150]  B. Sykes,et al.  Characterization of cells with high alkaline phosphatase activity derived from human bone and marrow: preliminary assessment of their osteogenicity. , 1985, Bone.